Mayo Clinic Laboratories > Oncology > Breast and Gynecological Cancer

Breast and Gynecological Cancer

Comprehensive testing. Accurate, actionable results.

Mayo Clinic Laboratories’ gynecological cancer and breast cancer treatment tests are designed to provide a detailed picture of a patient’s cancer diagnosis to help clinicians get needed information to guide care decisions. From testing to diagnosis to treatment, our comprehensive selection of tests is designed to make Mayo Clinic Laboratories a one-stop shop for gynecological and breast cancer care.

Gynecological cancer Gynecological cancer
GynecologicAL cancer

Our MayoComplete gynecological cancer panels use next-generation sequencing to evaluate genes with known relevance to diagnosis, prognosis, and treatment of uterine, ovarian, and endometrial cancers.

Rapid hereditary breast cancer Rapid hereditary breast cancer
Rapid hereditary breast cancer

Mayo Clinic Laboratories’ Rapid Breast Cancer Treatment Decision Panel is designed to detect 11 genes that are linked to lifetime breast cancer risk and deliver results within 10–14 days.

News and updates

The latest

Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D.

Maryam Shahi, M.D., explains how Mayo Clinic Laboratories' unique biomarker test (TEST ID: AFOLR) determines which patients would likely benefit from a new treatment for recurrent epithelial ovarian cancer. Disease recurrence is common, and about one-third of patients respond to the new medication.

Learn more
Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D.

Maryam Shahi, M.D., explains how Mayo Clinic Laboratories' unique biomarker test (TEST ID: AFOLR) determines which patients would likely benefit from a new treatment for recurrent epithelial ovarian cancer. Disease recurrence is common, and about one-third of patients respond to the new medication.

Breast cancer panel halves turnaround time: Wei Shen, Ph.D.

In this test-specific episode of the "Answers From the Lab" podcast, Wei Shen, Ph.D., explains how Mayo Clinic Laboratories' new breast cancer panel provides rapid results to guide critical decisions about treatment and screening.

Gynecological NGS panels offer cost-effective cancer testing: Sounak Gupta, M.B.B.S., Ph.D.

Sounak Gupta, M.B.B.S., Ph.D., explains how Mayo Clinic Laboratories' gynecological NGS panels provide focused assessments of gynecological cancers. The cost-effective tests fill the gap between single gene assays and large cancer panels, to inform prognosis and treatment.

INTERESTED IN LEARNING MORE?

Fill out the form below and one of our specialists will be in touch.

(BETA) Choose a language to view this content in:
About the translation.